Company Filing History:
Years Active: 2013
Title: The Innovations of Volker Böttger
Introduction
Volker Böttger is a notable inventor based in Germering, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of specific amino acid sequences that serve as target epitopes for antibodies.
Latest Patents
One of his key patents is titled "Binding epitopes for G250 antibody." This invention relates to specific amino acid sequences that have been identified as target epitopes for antibodies, especially for the G250 antibody. His innovative work in this area has the potential to advance therapeutic applications in medicine.
Career Highlights
Volker Böttger is associated with Wilex AG, a company that focuses on the development of innovative cancer therapies. His role at Wilex AG has allowed him to contribute to groundbreaking research and development in the field of oncology.
Collaborations
He has collaborated with Thorsten Wöhl, further enhancing the research efforts at Wilex AG. Their combined expertise has led to advancements in the understanding of antibody interactions and their applications in cancer treatment.
Conclusion
Volker Böttger's contributions to biotechnology and his innovative patent work exemplify the impact of dedicated inventors in the field of medicine. His ongoing research continues to pave the way for future advancements in cancer therapies.